Implantable Programmable Bipolar Cardiac (K800573)
510(k) K800573
Active
Valid until
No expiry
FDA recalls
None foundDocuments
Trust
Unverified
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | FDA 510(k)SESE | NumberK800573 | Date25 Mar 1980 | StatusActive |
Recalls
No FDA recalls found in the data synced 22 Oct 2026.
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
United States — FDA 510(k) Active
Specification
- Full name
- Implantable Programmable Bipolar Cardiac
- 510(k) Number
- FDA Product Code
- DXY
- Device Class
- Class III
- Regulation
- 21 CFR Part 870.3610
- Advisory Committee
- Cardiovascular
- FDA Decision
- SESE Substantially Equivalent
Overview
AI-generated summary, 18 Sep 2026
This device is an Implantable Pacemaker Pulse-Generator, classified under FDA regulation 870.3610. It is designed as a cardiac implant to deliver programmable electrical stimulation via bipolar leads, serving as a substitute for the heart’s intrinsic pacing functions in patients with bradycardia or conduction disorders.
The device is supplied sterile for single-use implantation and is intended for use in cardiovascular settings. It is classified as a Class III medical device under FDA regulations and received FDA 510(k) clearance (K800573) in 1980. No additional regulatory status beyond the stated clearance is implied.
Other devices from Telectronics, Inc.
Questions
AI-generated answers, 18 Sep 2026
What is the primary purpose of this implantable device, and how does it function in the body?
This device is an implantable pacemaker pulse-generator designed to replace the heart’s natural pacing functions in patients with bradycardia or conduction disorders. It delivers programmable electrical stimulation via bipolar leads to regulate heart rhythm, ensuring consistent contractions when the heart’s intrinsic electrical system fails.
Is this device intended for reuse, or is it meant to be implanted as a single-use item?
The device is sterile and supplied for single-use implantation only, meaning it is not designed for reuse. Once implanted, it remains in place as a permanent solution for the patient’s pacing needs.
What regulatory pathway was followed for this device’s approval, and which advisory committee reviewed it?
This device received FDA 510(k) clearance (K800573) under the Traditional 510(k) pathway, classified as substantially equivalent to a predicate device. The review was conducted by the FDA’s Cardiovascular (CV) Advisory Committee, reflecting its classification as a Class III medical device under regulation 870.3610.
How is this device typically supplied, and what should clinicians consider during storage?
The device is sterile-packaged for surgical implantation and comes pre-sterilized to ensure safety for direct patient use. Clinicians should store it in a clean, dry environment away from extreme temperatures or moisture, adhering to manufacturer guidelines for shelf life and handling to maintain sterility and functionality.